- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloma, Multiple
Total 12299 results
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
Mayo ClinicWithdrawnMultiple Myeloma | Refractory Multiple Myeloma
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Centre Hospitalier le MansCompleted
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
Oncopeptides ABWithdrawnMultiple Myeloma | Relapse Multiple MyelomaCzechia
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
Swiss Group for Clinical Cancer ResearchTerminatedRefractory Multiple MyelomaSwitzerland
-
Genesis Pharma S.A.CompletedRelapse/Refractory Multiple MyelomaGreece
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
PfizerCompletedAdvanced Multiple MyelomaUnited States
-
Allarity TherapeuticsMedical Prognosis Institute A/S; Smerud Medical Research International ASTerminatedRelapsed/Refractory Multiple MyelomaDenmark
-
Shenzhen Second People's HospitalUnknownMultiple Myeloma in RelapseChina
-
Herlev HospitalOdense University HospitalCompletedRelapsed Multiple MyelomaDenmark
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Italy
-
University of IowaCompleted
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
University of WuerzburgCompletedRefractory Multiple Myeloma | RelapseGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Chroma TherapeuticsCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited Kingdom
-
WiSP Wissenschaftlicher Service Pharma GmbHLudwig-Maximilians - University of Munich; Chugai Pharma GmbHCompletedHodgkin's Disease | Non-Hodgkin Lymphomas | Multiple Myelomas
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Spain, Australia, Brazil, United Kingdom, Poland, Taiwan, Singapore, France, Italy
-
Zhejiang ACEA Pharmaceutical Co. Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Second Affiliated Hospital, School of Medicine,...Carbiogene Therapeutics Co. Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Antengene CorporationActive, not recruiting
-
Molecular Templates, Inc.TerminatedRelapsed and/or Refractory Multiple MyelomaUnited States
-
Nanjing Legend Biotech Co.Ruijin Hospital; Second Affiliated Hospital of Xi'an Jiaotong University; Shanghai... and other collaboratorsActive, not recruitingRefractory or Relapsed Multiple Myeloma
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
Sorrento Therapeutics, Inc.CompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Multiple Myeloma
-
First Affiliated Hospital of Zhejiang UniversityCARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
The First Affiliated Hospital of Nanchang UniversityUnknownRelapsed or Refractory Multiple MyelomaChina
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Hebei Yanda Ludaopei HospitalUnknownRelapsed or Refractory Multiple MyelomaChina
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Epizyme, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B Cell Lymphoma Refractory | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Celyad Oncology SANational Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer InstituteCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina